Merck KGaA Unit Files Patent Suit Against Sepracor
The suit was filed Wednesday in New York on behalf of Napa, California-based Dey LP and Dey Inc., which are subsidiaries of Merck KGaA, according to court papers. Merck KGaA is distinct from the U.S.-based Merck & Co.
At issue is Sepracor’s Brovana inhalation solution, which was approved by the...
To view the full article, register now.